None listed
Conditions
Brief summary
The purpose of this study is to determine the acceptability of two different decision aids in assisting with making an informed decision about screening for prostate cancer. Who is it for? You may be eligible for this study if you are a male aged 45-60 years, who has not been diagnosed with prostate cancer. Study details Participants in this study will be randomised by chance to receive one of two online information sheets (referred to as ‘decision aids’). One version of the decision aid is short, while the other is slightly longer. Participants will then be asked to complete a questionnaire based on the information they have just received. It is hoped that this research will help determine which information tool will help better inform men about prostate cancer screening.
Interventions
Two decision aids designed and developed by researchers at the University of Sydney using evidence-based data applied to the Australian context. The team worked closely with a graphic designer to design and develop appropriate online version of the aids.
The full length decision aid (http://www.psatesting.org.au/home) is equivalent to 10 x A4 pages which translated to four screens online, and sub-screens. It presents information on screening outcomes and the expected frequency for each outcome,
Two decision aids designed and developed by researchers at the University of Sydney using evidence-based data applied to the Australian context. The team worked closely with a graphic designer to design and develop appropriate online version of the aids. The full length decision aid (http://www.psatesting.org.au/home) is equivalent to 10 x A4 pages which translated to four screens online, and sub-screens. It presents information on screening outcomes and the expected frequency for each outcome, each illustrated by icon arrays (1000-person tools and a conceptual diagram of overdiagnosis) and comprehensive information about overdiagnosis. The short decision aid (http://www.psatesting.org.au/info) is one double-sided A4 sheet or a single webpage. It contains similar key information but is simplified in text and table form only with no supporting graphic material. A summary table of outcomes (‘What happens over 20 years?’) comparing the options of screening versus not screening features in both versions. New to these aids is quantified information on treatment side effects and inclusion of information about considering one's life expectancy in screening decisions. A community sample of men will be recruited to participate in an online randomised controlled trial comparing the two decision aids. They will access the allocated decision aid online, at home, at the time that they complete the survey. The survey and decision aid will take approximately 15 minutes to complete. An image will appear at the end of the online decision aid instructing men to click on it to indicate that they clicked through all screens of the aid.
Sponsors
Sydney School of Public Health
Study design
Allocation
Randomised controlled trial
Primary purpose
Educational / counselling / training
Eligibility
Sex/Gender
Male
Age
45 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
Men eligible to participate if registered with the survey panel, accept an invitation to participate in the online questionnaire, and aged between 45 and 60 years, without a prostate cancer diagnosis.
Exclusion criteria
Previous prostate cancer diagnosis Outside 45-60 years age bracket
Outcome results
None listed